Hon. Sophia Moermond, on behalf of Hon. Ben Dawkins, questions the Premier regarding mRNA vaccine safety concerns and requests a pause on their use in WA, citing residual DNA and lipid nanoparticle risks. The Premier refers to the TGA's assessment responsibilities.

AnsweredQoN 1391Legislative Council
Asked
6 November 2024
Portfolio
Leader of the House representing the Premier

QuestionView source ↗

CORONAVIRUS — mRNA
VACCINE
1391. Hon SOPHIA MOERMOND to the Leader of the House
representing the Premier:
I ask this question on behalf of Hon Ben Dawkins . I refer to confirmation by the
Therapeutic Goods Administration that the
mRNA vaccine products used in Australia contain residual DNA; to the growing
global evidence that residual DNA and
lipid nanoparticle formulations may be potentially dangerous—particularly
the work of Angus Dalgleish , Dr Paul Marik, Dr David Speicher, Professor
Robert Clancy and many others; and to the recent motion passed by the Town of
Port Hedland.
(1) Does the
Premier acknowledge the concerns of many Western Australians that there are
valid questions that still need to be answered around the issue of mRNA vaccine
safety?
(2) Will the
Premier order an immediate pause in the use of these vaccines in WA until
further research is conducted?

AnswerView source ↗

(1)–(2) The
Therapeutic Goods Administration is responsible for assessing vaccines and
other medicines before they can be used in Australia.

Explore WA Government Data

Search the full archive in the free dashboard, or query programmatically via API.

Explore more